Why the study?
What is the impact of various antithrombotic agents on the outcomes of patients undergoing percutaneous transluminal coronary angioplasty?
What is the impact of various antithrombotic agents on the outcomes of patients undergoing percutaneous transluminal coronary angioplasty?
This review summarizes the use and impact of various antithrombotic agents in the setting of coronary angioplasty.
Answers are grounded in this paper and cite their sources.
Offers synthesis of antithrombotic options in angioplasty; extends literature but leaves open optimal regimens pending new trials.
The use of adjunctive pharmacologic therapy in the setting of coronary angioplasty has evolved in recent years with the introduction of new antithrombotics and better understanding of the pharmacologic properties of the drugs. This manuscript reviews the various antithrombotic agents currently in use and their impact on the outcomes of patients receiving them.
No takes yet. Share an insight, caveat, or question.
Cheem et al. (1997) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: